Skip to main content

Oregon State Flag An official website of the State of Oregon »

Public Health & Pharmacy Formulary Advisory Committee / Protocols

Statutory Authority 

The multidisciplinary Public Health and Pharmacy Formulary Advisory Committee (PHPFAC) was convened in 2018 pursuant to ORS 689.645 and 689.649. 

Laws & Rules 

The rules in OAR 855-115-0330 establish the pharmacist’s authority and responsibilities to prescribe drugs and devices, pursuant to the formulary and protocols developed and recommended by the Public Health and Pharmacy Formulary Advisory Committee (PHPFAC). These rules articulate the authority and legal expectations for an Oregon licensed pharmacist and practicing in Oregon, to voluntarily participate in providing patient assessment and patient care services that may result in the issuance of a prescription by a pharmacist for an identified medical need.

The rules describe the Board’s compliance expectations for pharmacy practice and prescribing from the formulary and protocol compendia. Standards defined include: (1) education and competency; (2) patient assessment and referral criteria; (3) collaboration with other healthcare, providers, including mandated notification; (4) treatment and follow-up care planning; (5) documentation and record-keeping; and (6) prohibited practices.

Oregon Board of Pharmacy laws and rules related to PHPFAC:


Protocol Compendium:


Formulary Compendium:


Concept Submission Form 

Complete the concept submission form below, attach all supporting documents and submit at least 42 days (6 weeks) prior to the date of the next committee meeting for consideration and potential review at an upcoming meeting. 

Email all Public Health & Pharmacy Formulary Advisory Committee related inquiries to

Fill out the form below to submit protocol feedback. 

Committee Members

  • Lorinda Anderson, RPH 
    • Term: 4/22/2024 - 4/21/2026

  • Andrew Gibler, RPH
    • Term: 5/1/2023 - 4/30/2025 

  • Katherine Hammond, APRN 
    • Term: 5/1/2023 - 4/30/2025

  • Robin Virgin, MD 
    • Term: 6/1/2024 - 5/31/2026

  • Courtney Sellers, RPH 
    • Term: 5/1/2024 - 4/30/2026

  • Mark Meyers, MD 
    • Term: 5/1/2023 - 4/30/2025 

  • Sarah Wickenhagen, APRN 
    • Term: 4/22/2024 - 4/21/2026 

Meeting Schedule


Email all Public Health & Pharmacy Formulary Advisory Committee related inquiries to